These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 15780399

  • 1. Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma.
    Yuan J, Takahashi A, Masumori N, Uchida K, Hisasue S, Kitamura H, Itoh N, Tsukamoto T.
    Urology; 2005 Mar; 65(3):594-9. PubMed ID: 15780399
    [Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG, Zhang ZW, Xin DQ, Shi CJ, Wu JP, Guo YL, Guan YF.
    Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
    [Abstract] [Full Text] [Related]

  • 3. Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia.
    Zang C, Liu H, Posch MG, Waechter M, Facklam M, Fenner MH, Ruthardt M, Possinger K, Phillip Koeffler H, Elstner E.
    Leuk Res; 2004 Apr; 28(4):387-97. PubMed ID: 15109539
    [Abstract] [Full Text] [Related]

  • 4. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS, Chen WC, Bai X, Wang YD.
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [Abstract] [Full Text] [Related]

  • 5. The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells.
    Shim J, Kim BH, Kim YI, Kim KY, Hwangbo Y, Jang JY, Dong SH, Kim HJ, Chang YW, Chang R.
    Int J Oncol; 2010 Jan; 36(1):223-31. PubMed ID: 19956851
    [Abstract] [Full Text] [Related]

  • 6. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R, Servidei T, Mirabella M, Rutella S, Mangiola A, Maira G, Mastrangelo R, Koeffler HP.
    Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
    [Abstract] [Full Text] [Related]

  • 7. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
    Takashima T, Fujiwara Y, Hamaguchi M, Sasaki E, Tominaga K, Watanabe T, Oshitani N, Higuchi K, Arakawa T.
    Oncol Rep; 2005 Apr; 13(4):601-6. PubMed ID: 15756430
    [Abstract] [Full Text] [Related]

  • 8. The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells.
    Yoshimura R, Matsuyama M, Hase T, Tsuchida K, Kuratsukuri K, Kawahito Y, Sano H, Segawa Y, Nakatani T.
    Int J Mol Med; 2003 Dec; 12(6):861-5. PubMed ID: 14612958
    [Abstract] [Full Text] [Related]

  • 9. Peroxisome proliferator-activated receptor gamma is frequently underexpressed in renal cell carcinoma.
    Yuan J, Takahashi A, Masumori N, Itoh N, Tsukamoto T.
    Int J Urol; 2006 Mar; 13(3):265-70. PubMed ID: 16643621
    [Abstract] [Full Text] [Related]

  • 10. Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines.
    Begum NM, Nakashiro K, Kawamata H, Uchida D, Shintani S, Ikawa Y, Sato M, Hamakawa H.
    Int J Oncol; 2002 Mar; 20(3):599-605. PubMed ID: 11836575
    [Abstract] [Full Text] [Related]

  • 11. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P, Thalhammer T, Jäger W, Aust S, Steiner G, Ensinger C, Obrist P.
    Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
    [Abstract] [Full Text] [Related]

  • 12. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma.
    Eucker J, Sterz J, Krebbel H, Zavrski I, Kaiser M, Zang C, Heider U, Jakob C, Elstner E, Sezer O.
    Anticancer Drugs; 2006 Aug; 17(7):763-9. PubMed ID: 16926626
    [Abstract] [Full Text] [Related]

  • 13. EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
    Chbicheb S, Yao X, Rodeau JL, Salamone S, Boisbrun M, Thiel G, Spohn D, Grillier-Vuissoz I, Chapleur Y, Flament S, Mazerbourg S.
    Biochem Pharmacol; 2011 May 01; 81(9):1087-97. PubMed ID: 21338579
    [Abstract] [Full Text] [Related]

  • 14. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
    Ward JE, Gould H, Harris T, Bonacci JV, Stewart AG.
    Br J Pharmacol; 2004 Feb 01; 141(3):517-25. PubMed ID: 14718259
    [Abstract] [Full Text] [Related]

  • 15. Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats.
    Yamamoto Y, Ono T, Dhar DK, Yamanoi A, Tachibana M, Tanaka T, Nagasue N.
    J Gastroenterol Hepatol; 2008 Jun 01; 23(6):930-7. PubMed ID: 18565023
    [Abstract] [Full Text] [Related]

  • 16. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
    Liu J, Xia Q, Zhang Q, Li H, Zhang J, Li A, Xiu R.
    Shock; 2009 Sep 01; 32(3):317-24. PubMed ID: 19174742
    [Abstract] [Full Text] [Related]

  • 17. Peroxisome proliferator-activated receptor gamma and growth inhibition by its ligands in uterine endometrial carcinoma.
    Ota K, Ito K, Suzuki T, Saito S, Tamura M, Hayashi S, Okamura K, Sasano H, Yaegashi N.
    Clin Cancer Res; 2006 Jul 15; 12(14 Pt 1):4200-8. PubMed ID: 16857792
    [Abstract] [Full Text] [Related]

  • 18. Peroxisome proliferator-activated receptor gamma ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells.
    Yasugi E, Horiuchi A, Uemura I, Okuma E, Nakatsu M, Saeki K, Kamisaka Y, Kagechika H, Yasuda K, Yuo A.
    Dev Growth Differ; 2006 Apr 15; 48(3):177-88. PubMed ID: 16573735
    [Abstract] [Full Text] [Related]

  • 19. Peroxisome proliferator-activated receptor gamma ligands improve the antitumor efficacy of thrombospondin peptide ABT510.
    Huang H, Campbell SC, Bedford DF, Nelius T, Veliceasa D, Shroff EH, Henkin J, Schneider A, Bouck N, Volpert OV.
    Mol Cancer Res; 2004 Oct 15; 2(10):541-50. PubMed ID: 15498928
    [Abstract] [Full Text] [Related]

  • 20. Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy.
    Suwaki N, Masuyama H, Masumoto A, Takamoto N, Hiramatsu Y.
    Placenta; 2007 Apr 15; 28(4):315-23. PubMed ID: 16753211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.